OraPharma, Inc. Release: New ARESTIN(R) Website Provides Dental Professionals and Consumers With the Latest Periodontal Disease Information and Resources

Published: May 02, 2007

WARMINSTER, PA -- (MARKET WIRE) -- May 02, 2007 -- OraPharma, Inc., a specialty pharmaceutical company specializing in the discovery, development, and commercialization of therapeutics for the treatment of periodontal disease, including ARESTINĀ® (minocycline hydrochloride) Microspheres, 1 mg, recently launched the third generation of its popular web site, www.ARESTIN.com.

Back to news